Description of Collaborative Activity: |
Consortium that includes academia and representatives from the Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institutes on Alcohol Abuse and Alcoholism (NIAAA), National Institute on Drug Abuse (NIDA) and the pharmaceutical industry working together to identify and clarify clinical trials methodology to evaluate medications for treating alcohol dependence. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|